Organization · Accelerator
CancerX
CancerX is a public-private partnership focused on accelerating innovation in cancer care, launched by the White House Cancer Moonshot in February 2023. It aims to enhance access to digital solutions for cancer treatment through collaboration among various stakeholders.
Overview
What CancerX does
What CancerX is
CancerX is a public-private partnership focused on accelerating innovation in cancer care, launched by the White House Cancer Moonshot in February 2023. It aims to enhance access to digital solutions for cancer treatment through collaboration among various stakeholders.
How it participates in the startup ecosystem
The current public profile supports funder and program host capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Accelerator
- Founded
- Founded in 2023
- Approximate age
- About 3 years
- Structured capabilities
- Funder · Program host
- Last reviewed
- April 10, 2026
What Accelerator means
An accelerator is a structured, short-term program designed to speed up a startup's progress toward product-market fit, traction, fundraising, or scale.
Open the glossary entryOfficial channels
Find CancerX elsewhere
Open the official website or a supported primary organization account.
Capability profile
CancerX as a funder
Investment thesis
CancerX is dedicated to accelerating innovation in cancer care through digital solutions and collaboration among stakeholders.
Focus narrative
CancerX focuses on advancing digital innovation in oncology through collaboration among various stakeholders, including government partners, healthcare providers, and technology companies. Their current priority areas include Screening & Early Diagnostics, Treatment Decision & Monitoring, Treatment Innovation, and Access and Patient Experience.
Value beyond capital
CancerX provides a platform for startups to collaborate with industry champions and leading investors, facilitating innovation in cancer research, prevention, and treatment.
Focus and fit
- Stages
- Accelerator
- Sectors
- HealthcareDigital Health
- Regions
- United States
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 12
Portfolio context
CancerX has announced its 2026 Accelerator cohort, which includes 12 startups developing solutions aimed at transforming cancer prevention, diagnosis, and treatment. Notable companies in this cohort include Banting AI, CareYaya Health Technologies, Cerula Care, Cystotech ApS, Entia, F-U Cancer, LivAi Inc, MyCareGorithm, OncoBrain, The WiTT Group, Inc., Tono Health, and WittGen Inc.
Capability profile
CancerX as a program host
Program thesis
CancerX is a public-private partnership established to accelerate innovation in the fight against cancer, leveraging digital solutions to improve cancer care.
Focus narrative
CancerX focuses on advancing digital innovation in oncology through collaboration among various stakeholders, including government partners, healthcare providers, and technology companies. Their current priority areas include Screening & Early Diagnostics, Treatment Decision & Monitoring, Treatment Innovation, and Access and Patient Experience.
Value and support
The CancerX Accelerator program is designed to catalyze innovation in cancer research, prevention, and treatment. It brings together industry champions, leading investors, and promising startups to address real-world gaps in cancer care.
Format and cadence
- Typical cohort
- 12 companies
Availability
- Application state
- Not published
Focus and fit
- Stages
- Accelerator
- Sectors
- HealthcareDigital Health
- Regions
- United States
Alumni and track record
Alumni context
Notable companies in the 2026 Accelerator cohort include Banting AI, CareYaya Health Technologies, Cerula Care, Cystotech ApS, Entia, F-U Cancer, LivAi Inc, MyCareGorithm, OncoBrain, The WiTT Group, Inc., Tono Health, and WittGen Inc. These companies represent a range of technology-enabled approaches to enhance cancer care delivery and improve patient outcomes.
Common questions
What to know about CancerX
Upseed classifies CancerX under the Accelerator organization type. Its current public profile includes funder and program host capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 10, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.